Welcome to the Wyoming Chapter of the American College of Cardiology
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
For more information and to register, please visit: ACC Rockies Chapter Meeting 2026
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- AI-Enabled Clinician: Best Practices of Wearables in Cardiovascular CareIn this episode, Drs. Ami Bhatt, Rupal O’Quinn, and Leon Ptaszek delve into the role of consumer wearables in cardiovascular care.
- ACC Community Health Fairs Offer Framework For Closing Gaps in CareA Viewpoint published in JACC: Advances makes the case that addressing persistent inequities in cardiovascular health will require scalable, community-centered approaches that bring care, education, and preventive services directly into the communities where people live.
- Leadership Gap in Structural Heart Disease Trials PersistsWomen remain underrepresented in authorship and leadership roles of clinical trials of structural heart disease (SHD), and targeted efforts and policies to diversify trial leadership may help address the downstream inequities in the generation of cardiovascular evidence, according to a systematic review and meta-analysis published Aug. 12 in JACC: Advances.
- COMBINE-AF: Extracranial Bleeding Common With OAC in AFib TreatmentClinically relevant extracranial bleeding affected approximately one in four patients receiving oral anticoagulation (OAC) for atrial fibrillation (AFib) over two years, potentially providing a more comprehensive measure of bleeding burden than major bleeding alone, according to a recent COMBINE-AF analysis published in Circulation.
- Long-Term ASCVD Risk Drives Expanded Statin Eligibility By 2026 Dyslipidemia GuidelineNearly 25 million more adults in the U.S. are eligible for statin therapy, based on recommendations in the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline, compared with the previous guideline, according to original research published Aug. 12 in JACC.